Article
Phakic IOL delivers good results in FDA trial for myopia
Anaheim, CA-An increasing number of IOLs are being developed to achieve improved vision in patients with extreme levels of myopia. One such lens is the Artisan/ Verisyse phakic IOL (Ophtec USA/Advanced Medical Optics), said R. Doyle Stulting, MD, PhD, who reported the results of the FDA clinical study here at the American Academy of Ophthalmology annual meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
